In the BioHarmony Drug Report Database

"Preview" Icon

Cilastatin

Primaxin, Recarbrio (cilastatin) is a small molecule pharmaceutical. Cilastatin was first approved as Primaxin on 1985-11-26. It is used to treat bacterial endocarditis, infectious arthritis, infectious bone diseases, infectious skin diseases, and intraabdominal infections amongst others in the USA. It has been approved in Europe to treat gram-negative bacterial infections. The pharmaceutical is active against dipeptidase 1.

 

Trade Name

 

Recarbrio
 

Common Name

 

cilastatin
 

ChEMBL ID

 

CHEMBL766
 

Indication

 

bacterial endocarditis, gram-negative bacterial infections, infectious arthritis, infectious bone diseases, infectious skin diseases, intraabdominal infections, respiratory tract infections, urinary tract infections
 

Drug Class

 

Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)

Image (chem structure or protein)

Cilastatin structure rendering